Skip to main content
OpenTrials

Clinical trial condition

Nephritis

Explore clinical trials studying Nephritis. Study availability and eligibility vary by location and protocol.

616 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Nephritis trial results

Completed

Controlled Trial Evaluating Avacopan in C3 Glomerulopathy

NCT03301467

Conditions
C3 Glomerulopathy (C3G), Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations
  • Clinical Site Palo Alto, California, United States
  • Clinical Site Chicago, Illinois, United States
  • Clinical Site Iowa City, Iowa, United States
  • Clinical Site Boston, Massachusetts, United States
View all 45 locations
View Trial Details
Completed

A Study of CCX140-B in Subjects With FSGS

NCT03536754

Conditions
FSGS, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • AKDHC Phoenix, Arizona, United States
  • Los Angeles Biomedical Research Institute Torrance, California, United States
  • Northwest Louisiana Nephrology Shreveport, Louisiana, United States
  • MGH Boston, Massachusetts, United States
View all 37 locations
View Trial Details
Completed

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

NCT02384317

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Palo Alto, California, United States
  • San Francisco, California, United States
  • Reno, Nevada, United States
  • Chapel Hill, North Carolina, United States
View Trial Details
Completed

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

NCT04145440

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • North America Research Institute Azusa, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States
  • University of Miami Division of Nephrology & Hypertension Miami, Florida, United States
View all 45 locations
View Trial Details
Completed

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

NCT03453619

Conditions
Autoimmune Diseases, C3 Glomerulonephritis, Connective Tissue Diseases, +18 more
Locations
  • Stanford University Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • HealthONE Physician Care, Rocky Mountain Hospital for Children Denver, Colorado, United States
  • Washington Nephrology Associates Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Completed

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)

NCT04541043

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • 13 Investigator sites Palo Alto, California, United States
  • 4 Investigator sites Buenos Aires, Argentina
  • 6 Investigator sites Melbourne, Australia
  • 3 Investigator sites Minsk, Belarus
View all 18 locations
View Trial Details
Completed

Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)

NCT04733040

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Managadze National Center of Urology Tbilisi, Georgia
  • Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic Tbilisi, Georgia
  • University Hospital Aachen Aachen, Germany
  • Charite Berlin, Germany
View all 25 locations
View Trial Details
Completed

Plasma NGAL in APN Patients

NCT06802796

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +7 more
Locations
  • Elsayed Abdelhalim Elsayed Zagazig, Egypt
View Trial Details

Related conditions